Science
OptraSCAN On-Demand Digital Pathology to Provide Robust Multiparametric Whole Slide Imaging System to the NINDS for Brain Injury Studies OptraSCAN has been chosen by the National Institute of Neurological Disorders and Stroke (NINDS), NIH to...
Last month a joint consensus statement developed by ASCO, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP) on standardizing the interpretation and reporting of sequence variants in cancer was...
Research agreement creates academic collaboration to develop deep learning tools for rapid onsite evaluation of adequacy (ROSEA) December 1, 2016 Mikroscan Technologies, maker of affordable desktop real-time telemicroscopy solutions, announces...
medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as "simple and...
Previous posts on this matter referenced that even with the funding proposed in the hundreds of millions dollars (estimated $750 million proposal) a lot more would be required. I believe one critic I referenced said that even with that amount...
A recent news brief service recently sent out highlights about a new study published in NEJM that questions the value of mammography for breast cancer screening while critics cited in the news brief call the study "deeply flawed" and suggest...
